R&D Expenses
$1.88B
TTM · Period ending: · USD

GMAB R&D Expenses
What is r&d expenses?
Research and development spending.
GMAB r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (USD) | Change |
|---|---|---|
| 1,560,229,544 | −83.99% | |
| 9,748,000,000 | +27.76% | |
| 7,630,000,000 | +37.18% | |
| 5,562,000,000 | +33.03% | |
| 4,181,000,000 | +33.28% | |
| 3,137,000,000 | +31.48% | |
| 2,386,000,000 | +66.72% | |
| 1,431,159,000 | +63.70% | |
| 874,278,000 | +32.29% | |
| 660,876,000 | +35.52% | |
| 487,656,000 | −3.56% | |
| 505,679,000 | −4.15% | |
| 527,576,000 | −1.70% | |
| 536,702,000 | — | |
| 0 | — | |
| 0 | −100.00% | |
| 935,361,000 | −34.26% | |
| 1,422,770,000 | +130.03% | |
| 618,503,000 | +71.83% | |
| 359,953,000 | +18.37% | |
| 304,103,000 | −18.54% | |
| 373,330,000 | +7.90% | |
| 345,983,000 | −12.68% | |
| 396,234,000 | — |
Frequently asked questions: GMAB r&d expenses
What is Genmab A/S (GMAB)'s current r&d expenses?
Genmab A/S (GMAB)'s latest reported r&d expenses (TTM) is $1.88B as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for GMAB?
Stock Alarm Pro provides 24 dated annual fiscal periods observations for Genmab A/S (GMAB)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GMAB's r&d expenses to peers or set an alert?
You can open GMAB's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GMAB delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance